[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"normotensive\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:normotensive":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":5},"100358538","normotensive-osa-patients-with-dipper-circadian-blood-pressure-pattern-100358538",false,"NCT03948373","Normotensive OSA Patients With Dipper Circadian Blood Pressure Pattern","CPAP Effect in Nocturnal Blood Pressure in Normotensive Patients With Dipper Circadian Pattern and Severe Obstructive Sleep Apnea (OSA)","Inclusion Criteria:\n\n1. Men and women over 18 years of age\n2. Referred to the sleep unit for suspected OSA\n3. Being normotensive and presenting an AHI ≥ 30 in the sleep study\n4. Signature of the informed consent.\n\nExclusion Criteria:\n\n1. Previous CPAP treatment\n2. Significant somnolence defined by an Epworth Sleepiness Scale (ESS) score higher than 18\n3. Psychophysical inability to complete questionnaires\n4. Previous diagnosis or suspicion of another sleep disorder\n5. Presence of more than 50% of central apneas or Cheyne-Stokes respiration\n6. Having a serious chronic disease: neoplasia, renal failure, severe chronic obstructive pulmonary disease, chronic depression and other chronic limiting diseases\n7. Medical history that may interfere with the objectives of the study or, in the opinion of the researcher, may compromise the conclusions\n8. Any medical, social or geographical factor that may endanger the patient's compliance 9-Having a profession of high risk (professional driver).","ALL","18 Years","100 Years",{"count":20,"type":21},64,"ESTIMATED","INTERVENTIONAL",[24],"NA","The principal objective is to evaluate the effect of CPAP treatment on blood pressure (BP) in normotensive patients with dipper circadian pattern with sleep apnea-hypopnea syndrome (SAHS). The secondary objectives are: i) To evaluate the prevalence of the different circadian patterns of BP in ambulatory blood pressure monitoring (ABPM) ii) To establish the relationship between CPAP compliance and BP response; iii) Identify which ABPM variables and biomarkers are related to BP response; iv) Evaluate changes in the biomarkers' profile with the CPAP treatment. Methodology: Open-label, parallel, prospective, randomized and controlled trial including normotensive patients diagnosed with severe SAHS without significant somnolence. 64 patients with dipper circadian pattern will be included and will be randomized to receive CPAP (32) or conservative treatment (32). ABPM and blood sample collection will be performed at the beginning of the study and at 3 months.",[27,28],"Normotensive","Sleep Apnea, Obstructive","RECRUITING","2025-02-25",{"date":32,"type":33},"2025-02-26","ACTUAL",{"date":35,"type":33},"2019-05-07",{"date":37,"type":21},"2025-12",{"name":39,"class":40},"Sociedad Española de Neumología y Cirugía Torácica","OTHER"]